Role of Intravenous Magnesium in the Management of Moderate to Severe Exacerbation of Asthma: A Literature Review.
Publication/Presentation Date
9-1-2022
Abstract
Asthma is a respiratory disorder marked by bronchial irritation and hyperresponsive airway smooth muscle. According to new research, magnesium's dual activity as an anti-inflammatory and bronchodilator may be important in asthma therapy. The goal of this study was to see how effective intravenous magnesium sulfate is in treating severe acute asthma. In addition to checking Clinicaltrials.gov, we ran a database search in Scopus, Google Scholar, PubMed, and Embase. Studies were chosen based on predetermined inclusion and exclusion criteria to prevent the chance of bias. Most researchers believed that intravenous magnesium sulfate improved symptoms and lung function significantly. Mortality and morbidity data were not available.
Volume
14
Issue
9
First Page
28892
Last Page
28892
ISSN
2168-8184
Published In/Presented At
Bokhari, S. A., Haseeb, S., Kaleem, M., Baig, M. W., Khan, H. A. B., Jafar, R., Munir, S., Haseeb, S., & Bhutta, Z. I. (2022). Role of Intravenous Magnesium in the Management of Moderate to Severe Exacerbation of Asthma: A Literature Review. Cureus, 14(9), e28892. https://doi.org/10.7759/cureus.28892
Disciplines
Medicine and Health Sciences
PubMedID
36225425
Department(s)
Fellows and Residents
Document Type
Article